Abstract:During the past decade, epigenetic control of cardiac remodeling has attracted attention as a major mechanism contributing to heart failure. The BET family of bromodomain proteins (BRD) functions as “readers” of acetylated chromatin. Pharmacological inhibition of BRD proteins prevents cardiac hypertrophy and heart failure in preclinical models, yet mechanistic studies elucidating the biology of BRD proteins in the heart are lacking. Here, we investigated the role(s) of BRD4 in cardiac physiology and pathophysiology. By engineering a cardiomyocyte-specific BRD4 knockout mouse, we discovered that loss of BRD4 triggered progressive decline in ventricular contractile function, culminating in dilated cardiomyopathy in both post-natal and adult hearts. To identify early transcriptomic changes in BRD4-ablated heart, we conducted a global transcriptome analysis in KO hearts prior to the onset of ventricular dysfunction. RNA sequencing analysis of BRD4 KO hearts revealed disruption of genes essential to mitochondrial energy production and homeostasis, as well as key cardiac sarcomeric components. Computational analysis identified key transcription factors involved in BRD4-mediated gene regulation, including MEF2 complex, ERR1, SRF, and Nkx2.5. By studying isolated cardiomyocytes maintained in primary culture, we confirmed that disruption of the candidate TF complexes by BRD4 ablation altered mitochondrial morphology and provoked progressive contractile dysfunction. In aggregate, we describe for the first time a critical role of BRD4 in regulating key cardiomyocyte gene networks, in particular genes involved in mitochondrial homeostasis and contractility, to maintain cardiac function. Moreover, our data suggest that BRD4 is a novel regulator of epigenetic events in dilated cardiomyopathy. Elucidating these novel roles of BRD4 in cardiomyocyte remodeling will provide critical insights into the epigenetic control of stress-related cardiac events with potential clinical relevance.

BRD4 phosphorylation regulates the structure of chromatin nanodomains

Interplay of condensation and chromatin binding underlies BRD4 targeting

Roles of the BRD4 Short Isoform in Phase Separation and Active Gene Transcription

Structural Basis and Binding Properties of the Second Bromodomain of Brd4 with Acetylated Histone Tails.

Phosphorylation by JNK switches BRD4 functions

Signal-induced Brd4 Release from Chromatin is Essential for Its Role Transition from Chromatin Targeting to Transcriptional Regulation

Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution

A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT

Histone Cross-talk Connects Protein Phosphatase 1α (PP1α) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression

Bromodomains regulate dynamic targeting of the PBAF chromatin-remodeling complex to chromatin hubs

Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.

DNA Damage Induces Dynamic Associations of BRD4/P-TEFb with Chromatin and Modulates Gene Transcription in a BRD4-Dependent and -Independent Manner.

BRD4 Regulates Nanog Expression in Mouse Embryonic Stem Cells and Preimplantation Embryos

The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain

BET Bromodomain Protein 4 (BRD4) Governance of Cardiovascular Disease Stress-related Cardiomyocyte Remodeling

BRD2 compartmentalizes the accessible genome

BRD4: a general regulator of transcription elongation

BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones

Solution Structure of Human Brg1 Bromodomain and Its Specific Binding to Acetylated Histone Tails.